KCM
COLL icon

Kennedy Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Kennedy Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-24,194
Closed -$278K – 690
2019
Q3 		$278K Sell
24,194
-680
-3% -$7.76K 0.01% 667
2019
Q2 		$327K Buy
+24,874
New +$333K 0.01% 668

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Kennedy Capital Management's COLL Position: Q4 2019 in Review

Kennedy Capital Management sold out of Collegium Pharmaceutical (COLL) in Q4 2019, closing a stake of 24,194 shares — an estimated $278K sold.

Kennedy Capital Management first reported a position in COLL in Q2 2019 and held it in 2 quarters. The position peaked at $327K in Q2 2019. 138 funds tracked by Wall St. Rank hold COLL as of Q4 2019.

  • Kennedy Capital Management reported no remaining Collegium Pharmaceutical position as of Q4 2019 after selling out during the quarter.
  • Kennedy Capital Management sold 24,194 Collegium Pharmaceutical shares in Q4 2019, an estimated $278K.
  • Kennedy Capital Management first reported a position in Collegium Pharmaceutical in Q2 2019 and held it in 2 quarters.
  • Kennedy Capital Management's Collegium Pharmaceutical position peaked at $327K in Q2 2019.
  • 138 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2019.

Based on Kennedy Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.